In Vitro Efficacy of Polysaccharide-Based Nanoparticles Containing Disease-Modifying Antirheumatic Drugs

The multiple facets of glucocorticoid action in rheumatoid arthritis

(2012) Ulrike Baschant et al.   Nature Reviews Rheumatology

Biodegradable chitosan particles induce chemokine release and negligible arginase-1 activity compared to IL-4 in murine bone marrow-derived macrophages

(2011) Jessica Guzmán-Morales et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Evaluation of SV40-transformed synovial fibroblasts in the study of rheumatoid arthritis pathogenesis

(2011) K. L. Wagoner et al.   RHEUMATOLOGY INTERNATIONAL

Chitosan Nanoparticles: A Promising System in Novel Drug Delivery

(2010) Kalpana Nagpal et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

Luteolin suppresses IL-1β-induced cytokines and MMPs production via p38 MAPK, JNK, NF-kappaB and AP-1 activation in human synovial sarcoma cell line, SW982

(2010) Eun Mi Choi et al.   FOOD AND CHEMICAL TOXICOLOGY

Prediction of response to disease modifying antirheumatic drugs in rheumatoid arthritis

(2010) Jean-Francis Maillefert et al.   JOINT BONE SPINE

Methotrexate—how does it really work?

(2010) Edwin S. L. Chan et al.   Nature Reviews Rheumatology

Polysaccharide-Based Polyelectrolyte Complex Nanoparticles from Chitosan, Heparin, and Hyaluronan

(2009) Soheil Boddohi et al.   BIOMACROMOLECULES

Polysaccharides-based nanoparticles as drug delivery systems

(2008) Zonghua Liu et al.   ADVANCED DRUG DELIVERY REVIEWS